Tenax Therapeutics Announces Pricing Of ~$9M Public Offering Of 1.6M Shares And 3.2M Warrants At $5.65 Per Share And Associated Common Warrant
Portfolio Pulse from Benzinga Newsdesk
Tenax Therapeutics has announced the pricing of a public offering, aiming to raise approximately $9 million through the sale of 1.6 million shares and 3.2 million warrants. Each share is priced at $5.65 and comes with an associated common warrant.
February 08, 2024 | 1:18 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Tenax Therapeutics is raising approximately $9 million through a public offering of 1.6 million shares and 3.2 million warrants, each priced at $5.65.
Public offerings often lead to short-term downward pressure on a company's stock price due to the dilution of existing shares. Given the size of the offering relative to Tenax's market cap, this could have a significant impact.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100